Investigation for Investors in Shares of Osiris Therapeutics, Inc. (NASDAQ:OSIR) over Potential Wrongdoing by Certain Directors Announced
Certain directors of Osiris Therapeutics, Inc. are under investigation concerning possible wrongdoing. The investigation was announced for current long-term investors in NASDAQ:OSIR shares over potential breaches of fiduciary duties by certain officers and directors at Osiris Therapeutics.
View full press release